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Validation of a new predictive risk model:
measuring the impact of the major modifiable
risks of death for patients and populations
Stephen S. Lim1*, Emily Carnahan1, Eugene C. Nelson2, Catherine W. Gillespie1, Ali H. Mokdad1,
Christopher J. L. Murray1 and Elliott S. Fisher2
Abstract
Background: Modifiable risks account for a large fraction of disease and death, but clinicians and patients lack
tools to identify high risk populations or compare the possible benefit of different interventions.
Methods: We used data on the distribution of exposure to 12 major behavioral and biometric risk factors inthe US
population, mortality rates by cause, and estimates of the proportional hazards of risk factor exposure from
published systematic reviews to develop a risk prediction model that estimates an adult’s 10 year mortality risk
compared to a population with optimum risk factors. We compared predicted risk to observed mortality in 8,241
respondents in NHANES 1988-1994 and NHANES 1999-2004 with linked mortality data up to the end of 2006.
Results: Predicted risk showed good discrimination with an area under the receiver operating characteristic (ROC)
curve of 0.84 (standard error 0.01) for women and 0.84 (SE 0.01) for men. Across deciles of predicted risk, mortality
was accurately predicted in men ((Χ2 statistic = 12.3 for men, p=0.196) but slightly overpredicted in the highest
decile among women (Χ2 statistic = 22.8, p=0.002). Mortality risk was highly concentrated; for example, among
those age 30-44 years, 5.1 % (95 % CI 4.1 % - 6.0 %) of the male and 5.9 % (95 % CI 4.8 % - 6.9 %) of the female
population accounted for 25 % of the risk of death.
Conclusion: The risk model accurately predicted mortality in a representative sample of the US population and
could be used to help inform patient and provider decision-making, identify high risk groups, and monitor the
impact of efforts to improve population health.
Introduction
The aim of medicine is to reduce the burden of disease
[1]. This aim can be achieved by taking actions to pro-
mote health and prevent health problems or treat dis-
eases and disabilities after they impose their burden on
patients and populations. The evidence suggests a rela-
tively small number of modifiable risks account for a
large fraction of the burden of chronic diseases and pre-
mature death in the United States as well as the devel-
oped world [2–4]. Poor health due to modifiable risks
and the costs of treating the resulting disease and injury
threaten the affordability of health care. Efforts at preven-
tion or disease modification require not only accurate
information on modifiable risks but also the availability of
valid, reliable, practical, and actionable measures of these
modifiable risks so that those at risk can be identified and
interventions appropriately targeted [5–8].
Substantial progress has been made on both fronts in
recent years. The Global Burden of Disease initiative has
completed systematic reviews identifying and quantifying
the modifiable risks of death, disease, and disability in
developing and developed countries [9, 10]. Many useful
health risk measures have also been developed. Most,
however, focus on specific diseases [11, 12] or families of
related diseases, such as the widely used Framingham
cardiovascular risk index, [13] or on patients in specific
care settings who may be at risk for rapid deterioration,
such as the APACHE score for intensive care patients
[14] or risk indices for frail elderly patients who are hos-
pitalized and may be at risk for decubitus ulcers [15].
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Interest in measures of general health risks is also sub-
stantial, and many employers and some health systems
have adopted health risk appraisals (HRAs) to help their
health promotion and disease prevention initiatives.
Existing HRAs, however, are based on risk models that
have not been validated and published in the literature,
or have “black box” scoring algorithms that are not open
to scrutiny [16, 17].
To address these limitations, we developed a new,
non-proprietary, health risk model based on the most re-
cently available systematic reviews of the modifiable
risks of death in order to predict all-cause mortality for
adults in the United States. In this report, we describe
the validation of this model in a sample of US adults.
The findings suggest that the risk prediction model could
help individuals and clinicians by allowing them to iden-
tify and compare potential clinical and behavioral inter-
ventions, while allowing those responsible for defined
populations (such as primary care practices, accountable
care organizations, health plans, and employers) not only
to identify those individuals at greatest risk but also to
track changes in health risks over time.
Methods
The risk model computes an individual’s total risk of
mortality over the next 10 years based on exposure to 12
major risk factors (Table 1) for adults aged 30 years or
older. These risk factors were included based on reviews
of the scientific literature and represent a parsimonious
set of the most substantial, modifiable risk factors that
contribute to the probability of dying [2]. All risk factors
selected had to be (a) actionable: subject to modification
by clinical or behavioral interventions, (b) substantial:
contribute at least 0.20 years to mortality risk, and (c)
evidence-based: supported by recent meta-analyses [9].
We envisioned that the full survey instrument (provided
in Additional file 1) could be completed in multiple set-
tings, ranging from clinical visits to online surveys.
Risk score development and calculation
Figure 1 provides an overview of the data sources and
calculations involved in computing a risk score. We
briefly summarize the methods below and offer further
technical details in Additional file 2.
Overall mortality risk
An individual’s risk of mortality is determined by first
calculating, for each cause of death separately, the indi-
vidual’s overall relative risk of mortality compared to no
exposure to the 12 risk factors. We used previously pub-
lished systematic reviews to determine the relative risk
per unit increase in exposure to the 12 risk factors by
age and sex (Additional file 2). A multiplicative risk
model was used to calculate the relative risk of mortality
Table 1 List of risk factors with the corresponding exposure
metric
Risk factor Exposure metric
Excess body
weight
Body mass index (kg per m2)
High blood
pressure
Systolic blood pressure (mmHg)
High cholesterol LDL cholesterol (mg/dl)
High blood
glucose
Fasting plasma glucose (mg/dl)
Seat belts How often a seat belt is worn:
• Always or does not drive or ride in a car
• Nearly always
• Sometimes
• Seldom
• Never
Tobacco use Three smoking categories:
• Non-smoker
• Current smoker
• Former smoker
Alcohol use Includes both average consumption and
pattern of drinking (binge drinking)
Average consumption:
• Abstainer not having had a drink containing
alcohol in the last 30 days;
• 0–19.99 g of pure alcohol daily (females) and
0–39.99 g (males)
• 20–39.99 g (females) and 40–59.99 g (males);
• ≥40 g (females) and ≥60 g (males)
Binge drinking was defined as having at least one
occasion of five or more drinks in the last month
(men) or four or more drinks in the last month (women)
Physical activity Based on physical activity during the past 30 days:
• Inactive, no moderate or vigorous physical activity;
• Low-active, <2.5 h/wk of moderate activity or <600
MET min/wk;
• Moderately active: either ≥2.5 h/wk of moderate
activity or ≥1 h of vigorous activity; and ≥600 MET
min/wk;
• Highly active: ≥1 h/wk of vigorous activity and
≥1,600 MET min/wk.
Fruit intake Dietary fruit intake over the past 30 days (average
grams per day)
Vegetable intake Dietary vegetable intake over the past 30 days
(average grams per day)
Omega-3 fatty
acids intake
Dietary omega-3 fatty acids during the past 30 days
(average milligrams of eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) per day)
Nut intake Dietary nut and seed intake, including peanut butter
during the past 30 days (average grams per day)
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by cause across the 12 risk factors. The model takes into
account risk factor correlation (individuals having
higher/lower exposure to multiple risk factors due to
common socioeconomic or behavioral determinants),
and risk mediation (part of the risk associated with fac-
tors such as obesity may be mediated through other risk
factors such as blood pressure). An individual’s relative
risk of mortality by cause is multiplied by the annual
background mortality risk by cause to estimate an indi-
vidual’s overall mortality risk.
Avoidable mortality risk
An individual’s avoidable mortality risk, i.e., the mortal-
ity risk that could be avoided by reducing exposure to
the 12 risk factors to their optimum level, is calculated
as the individual’s overall mortality risk less the individ-
ual’s background mortality risk based on age and sex.
The background mortality risk is an estimate of the risk
of mortality over the next 10 years for an individual of
the same age and sex who is not exposed to any of the
12 risk factors. We use the currently observed age- and
sex-specific background mortality risk to predict an indi-
vidual’s future background risk of mortality following
standard life-table methodology; [18, 19] that is, a
woman currently aged 55 is exposed to the background
mortality risk of 55-year-old females for the next year,
and the background mortality risk of 56-year-old females
in the subsequent year, and so on. An individual’s
Fig. 1 Risk score calculation flowchart: data inputs, sources, and calculations
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relative risk of mortality by cause is assumed to be con-
stant over all future periods. An individual’s overall risk
of mortality from all causes over the next 10 years and
their remaining life expectancy are calculated using the
standard competing risk model [20].
Background mortality risk by cause
To determine the background mortality risk by cause for
the current period we combined information on (a) the
current distribution of exposure to the 12 risks by age
and sex using data from the National Health and Nutri-
tion Examination Survey (NHANES, 2003–2010) and
the Behavioral Risk Factor Surveillance System (BRFSS,
2006–2008); (b) age-, sex-, and cause-specific mortality
rates in 2010 from the Global Burden of Disease Study
2010; [21] and (c) relative risks by age, sex, and cause as-
sociated with exposure to the 12 risk factors from sys-
tematic reviews. The mortality rates have been adjusted
for errors in cause of death assignment using previously
described methods [22].
Currently observed age-, sex-, and cause-specific mor-
tality rates represent the rate at which individuals of that
age and sex group will die from a cause in a given year.
These rates reflect the current exposure to risk factors in
the population and their hazardous effects on mortality.
The fraction of mortality that is due to current exposure
to the 12 risk factors can therefore be determined by cal-
culating a population attributable fraction (PAF) by age,
sex, and cause; this was done by calculating the overall
relative risk due to the 12 risk factors for each respondent
in NHANES (2003–2010), taking into account risk factor
correlation and mediation [3]. The PAF for each age, sex,
and cause is calculated as the sample weighted sum of the
excess risk, i.e., the relative risk minus one, divided by the
sample weighted sum of the relative risk across all
NHANES respondents. To address selection bias we im-
puted missing risk factor values using multiple imputa-
tions and took the average across the 10 imputations. The
background mortality rate by cause is calculated as one
minus the PAF multiplied by the current mortality rate.
Mortality rates were converted to annual probabilities of
dying using the standard life table calculation [18, 19].
Risk score validation
We performed an out-of-sample validation test using
established methods and NHANES linked mortality data
through December 31, 2006, for respondents inter-
viewed between 1988 and 1994 and between 1999 and
2004. These data were not used in the construction of
the risk score. For each individual in the cohort we cal-
culated the predicted risk of mortality over the available
follow-up time period up to 10 years. The validation
assessed (a) discrimination: the ability of the risk model
to distinguish between those who die during the follow-
Fig. 2 Receiver operator characteristic (ROC) curve for risk score
(NHANES 1988–1994 and 1999–2004). Note: Males: green curve,
Females: red curve
Fig. 3 Comparison of predicted risk of death against observed risk
of death (NHANES 1988–1994 and 1999–2004)
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up period and those who survive by calculating the area
under the curve (AUC) for the receiver operating char-
acteristic curve; [23] and (b) calibration: the ability of
the risk model to predict the observed level of risk
across deciles of the population using the Hosmer-
Lemeshow Χ2 statistic. The validation was performed for
men and women and by age group.
Impact on life expectancy and distribution of risk
We examined life expectancy and distribution of risk for
the NHANES 2003–2010 cohort, a sample that is repre-
sentative of the US population. We calculated the in-
crease in life expectancy that would result from reducing
exposure to the optimum distribution for each individual
risk factor as well as the 12 risk factors jointly as previ-
ously described [3]. We also used the risk model to esti-
mate the 10-year total and avoidable risk of death for
each respondent from NHANES 2003–2010 and present
results on the concentration of risk.
All analyses were conducted in Stata 11 (Stata
Corporation, Texas).
Results
Accuracy of the mortality prediction: Risk model
validation
Additional file 1 summarizes the characteristics of the
8,241 NHANES respondents included in the validation
dataset. By the end of 2006, 696 deaths (419 men and 277
women) occurred in this cohort. The risk model was able
to discriminate well between individuals who died and
those who survived, with an area under the curve (AUC)
of 0.84 (SE = 0.01) for women and 0.84 (SE = 0.01) for
men (Fig. 2) for deaths from any cause. The risk model
also accurately predicted the risk of death across deciles
(Fig. 3) among men (Χ2 = 12.3, p = .196). Risk was slightly
overestimated in the highest risk decile among women
(Χ2 = 22.8, p = .002). These results indicate that the risk
model is sufficiently accurate for use as a predictor of
mortality risk.
What matters most: Impact of specific risk factors on US
and individual mortality risk
Table 2 shows the estimated effect on life expectancy of
shifting risk exposures to their optimum distribution
(i.e., no excess risk) within the NHANES 2003–2010 co-
hort, a proxy for the US population. The combined im-
pact of the 12 risk factors is substantial; life expectancy
would increase by more than nine years among men and
more than eight years among women. For the US adult
population as a whole, the model indicates that tobacco
smoking, high blood pressure, and excess body weight
are the modifiable risk factors with the largest effect on
current adult life expectancy. The model also enables
different risks to be identified, quantified, and compared
for counseling individual patients.
Identifying high-risk patients: Distribution of risk in a
population
The avoidable risk of death is heavily concentrated in a
relatively small fraction of the population, particularly at
younger ages (Fig. 4). Among males aged 30 to 44 years,
5.1 % (95 % CI 4.1–6.0 %) of males account for 25 % of
the avoidable risk of death in that age group. This is
similar in females aged 30 to 44 years, with 5.9 % (95 %
CI 4.8–6.9 %) of females accounting for 25 % of the
avoidable risk of death. In general, as the population
ages, this fraction tends to increase. For example, among
males aged 70 to 79, 13.9 % (95 % CI 11.1–16.6 %) of
males account for 25 % of avoidable mortality risk in
that age group, and among females aged 70 to 79 years,
11.7 % (95 % CI 9.2–14.1 %) of females account for 25 %
of avoidable mortality risk in that age group.
Discussion
While the need for accurate and actionable information
on modifiable health risks is well recognized, the risk
models currently available have important limitations,
largely because they either focus on a specific, important
cause of death [24] or because they are based on propri-
etary algorithms that may not be based on the most up-
to-date evidence and have not been validated in the gen-
eral US population. Individuals, clinicians, and others
therefore currently lack a broadly available, evidence-
based tool that would support more accurate identifica-
tion of risks, assessment and comparison of the potential
impact for individuals of different risk-modification
strategies, or identification of high-risk subgroups of the
population. The risk model described and validated here
attempts to overcome these limitations.
We developed a new risk model based on 12 major be-
havioral and biometric risks to health that predict an in-
dividual’s probability of dying over the next 10 years
compared to a population with an optimum distribution
of risk factors. The model is based on current scientific
Table 2 Life expectancy gains in the US population (in years) by removing risk factors
Smoking High
blood
pressure
Excess
body
weight
High
blood
sugar
High
cholesterol
Low
physical
activity
Low
nut
intake
Low
vegetable
intake
Low
fruit
intake
Low
omega-3
intake
Alcohol
intake
Inadequate
seat belt
use
Joint
effects
Male 3.20 2.50 2.30 1.57 1.33 1.27 0.87 0.76 0.72 0.62 0.58 0.24 9.59
Female 2.39 2.92 2.21 1.38 0.92 1.39 0.72 0.70 0.61 0.54 0.40 0.23 8.98
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evidence on risks to health and contemporaneous, high-
quality data on the distribution of risk exposures and
mortality rates in the US population. The model has ex-
cellent discrimination in a sample of the US population
[23]. The excellent and widely used Framingham Index
[24–26] typically has areas under the curve of between
0.75 and 0.80 for predicting cardiovascular endpoints
only [27]. This newly developed model has areas under
the curve of greater than 0.80 for both men and women
for the more difficult task of predicting mortality from
any cause and is constructed using the best available evi-
dence on the major modifiable causes of mortality.
The risk model offers promise as a tool to support in-
dividual decision-making. A recent systematic review
demonstrates the benefits of providing cardiovascular
risk information to individuals for discussion with their
families and physicians [28]. The results suggest that if
individuals understand the magnitude of their risk, they
are more likely to adopt or maintain healthy behaviors.
The review also found that information on overall risk is
likely to have a greater impact when it is paired directly
with education or counseling. As illustrated in Additional
file 3, this risk model can facilitate counseling and
decision-making by providing a systematic way for pa-
tients and clinicians to compare how different behavioral
or clinical interventions would likely influence risk. For
example, the importance of smoking cessation for most
smokers becomes obvious. The risk model can show pa-
tients how they might avoid medication use by increasing
physical activity or reducing weight, or conversely, the lost
benefits of failing to take prescribed medications. The risk
model also takes into account the effect of behavioral
modification on other biological risk factors included in
the risk score, e.g., the effect of reductions in body weight
on blood pressure. Presenting accurate, holistic, and bal-
anced information about the risks that patients face, in
conjunction with counseling about the importance of dif-
ferent options for change, could help align decision-
making with patients’ preferences – an important national
aim [28]. Implementing the model in a way that provides
an attractive and accessible tool for the general popula-
tion, e.g., through Internet or phone-based applications,
would also provide a way for individuals to self-assess
their risk and encourage contacts with healthcare pro-
viders to decrease risk.
Broad adoption of the risk model could offer other
important benefits. First, clinical practices, health sys-
tems, and workplace health programs that obtain com-
pleted surveys from their populations can accurately
stratify people according to their level of risk and de-
velop epidemiologically informed programs to reduce
risks. In the highest-risk subpopulation, individualized
multiple-risk-factor interventions, such as case manage-
ment and health coaching, could be a wise investment
[29]. Second, the measure could contribute to clinical
and public health research by providing a validated
composite endpoint for clinical trials of multiple-risk-
factor intervention programs. Third, the measure offers
a potential improvement over current quality indicators
that focus largely on intermediate outcomes (e.g., levels
of blood sugar, blood pressure, and cholesterol) that
have little intuitive meaning to patients and encourage
well-recognized hazards among providers. For example,
if the proportion of diabetics with well-controlled
HbA1c is used as a quality measure, some may be en-
couraged to label those with pre-diabetes as diabetic (in-
flating the denominator), and treatment efforts may be
focused on those with mild disease, in whom achieving
target levels is easier but less important. Performance
measured on the basis of improvement in predicted risk
could give greater credit to meaningful progress for
those at greatest risk, even if specified targets were not
achieved. In addition, the risk measure would in all like-
lihood be more parsimonious (i.e., one broad measure
of risk status versus many narrow measures) [30].
Finally, if broadly adopted within specific geographic
Fig. 4 Distribution of avoidable risk of mortality in the United States
by age and sex (NHANES 2003–2010)
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regions and mapped in ways that preserve confidential-
ity, the measure could provide a basis for collaboration
among providers and community stakeholders on initia-
tives to improve population health.
At the same time, the risk model has important
limitations. We made judgments about which risks to
include. For example, we did not include depression,
believing that screening and intervention (especially
for those at risk of suicide) has a different and more
pressing time horizon, and we judged trans fats to be
akin to an environmental risk that is difficult for an
individual to control or modify. The risk model is
based on the average American, and, although dif-
ferential risk exposure explains a large fraction of
geographic, racial, and socioeconomic factors, there
are likely to be residual differences in the underlying
risk of death between these groups. Although the
proportional hazards of risk exposure are largely
generalizable across different populations, [31] several
risk factors are based on self-report, and these re-
sponses may not be accurate or comparable across
populations. While all included risks have strong
evidence as predictors of mortality, the strength of
evidence for risk factor modification on reduction in
mortality differs across risks, with a greater body of
evidence available for risk factors such as high blood
pressure. Related to this, some of the evidence for
these risk factors is based on observational studies,
which are prone to potential confounding. Although
we split the development and validation datasets, our
use of the same broad data source (NHANES) for the
analysis may have caused us to overestimate the pre-
dictive validity. The risk score appears to be mainly
driven by cardio-metabolic factors and has not yet
been validated either for specific clinical populations
(e.g., cancer, arthritis, dementia) or for different racial,
ethnic, or socioeconomic groups. The risk score also
does not include a prediction of morbidity, which is
an important consideration particularly among older-
aged individuals, nor does it presently include a quan-
tification of the potential adverse effects, for example
of medication, to reduce exposure to risk factors. It
will be important for patients and clinicians to under-
stand these limitations, both about the relative magni-
tude of specific risks and the potential benefits of risk
factor modification and to conduct further validation
studies and to update the model as new evidence
accumulates. Finally, while the focus of the use of the
risk score presented in this paper is on individual-
level modification, this should also be balanced
against population-wide approaches for reducing risk
exposure.
Some of these limitations can be addressed or miti-
gated by implementing the risk model in diverse
practices and populations and by linking respondents’
original and subsequent risk factor scores to data on sur-
vival. This would facilitate continued improvement and
validation of the model. This will be increasingly pos-
sible as electronic health record-enabled environments
are adopted for large patient populations [32].
Conclusion
The need to balance downstream treatment of diseases
with upstream prevention is well recognized [6, 17, 29].
Legislative and other upstream actions are now a corner-
stone of risk reduction and in some countries they play
a key role in reducing non-communicable diseases. Pa-
tients, clinicians, and employers are faced with a wide
array of commercial health risk appraisal tools that aim
to catalyze prevention and health promotion. Incorpor-
ating a standardized, validated, freely available, transpar-
ent, and continuously refined method to measure,
summarize, and track the most important modifiable
risks of death within these tools would offer benefits to
patients, clinicians, and policymakers.
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